Indomethacin is an effective treatment in adults and children with bone Langerhans cell histiocytosis (LCH)
- PMID: 32862434
- DOI: 10.1111/bjh.17067
Indomethacin is an effective treatment in adults and children with bone Langerhans cell histiocytosis (LCH)
Keywords: Langerhans cell histiocytosis; adults; bone involvement; children; indomethacin.
References
-
- Morimoto A, Shioda Y, Imamura T, Kudo K, Kitoh T, Kawaguchi H, et al. Japan LCH Study Group. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study. Int J Hematol. 2018;108(2):192-8.
-
- Cantu MA, Lupo PJ, Bilgi M, Hicks MJ, Allen CE, McClain KL. Optimal therapy for adults with Langerhans cell histiocytosis bone lesions. PLoS One. 2012;7(8):e43257.
-
- Munn SE, Olliver L, Broadbent V, Pritchard J. Use of indomethacin in Langerhans cell histiocytosis. Med Pediatr Oncol. 1999;32(4):247-9.
-
- Han I, Suh ES, Lee SH, Cho HS, Oh JH, Kim HS. Management of eosinophilic granuloma occurring in the appendicular skeleton in children. Clin Orthop Surg. 2009;1(2):63-7.
-
- Braier J, Rosso D, Pollono D, Rey G, Lagomarsino E, Latella A, et al. Symptomatic bone Langerhans cell histiocytosis treated at diagnosis or after reactivation with indomethacin alone. J Pediatr Hematol Oncol. 2014;36(5):280-4.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical